Medicinal – Page 134

Things you wanted to know about fungal extracellular vesicles (but were afraid to ask)

mycolabadmin

Fungal extracellular vesicles are tiny particles released by fungal cells that play important roles in how fungi cause disease and how our immune system responds. These particles can either help fight infections or make them worse depending on the type of fungus and conditions involved. Scientists are discovering that these vesicles could potentially be used as vaccines and may explain why some antifungal drugs stop working.

Reevaluating the Value of (1,3)-β-D-Glucan for the Diagnosis of Intra-Abdominal Candidiasis in Critically Ill Patients: Current Evidence and Future Directions

mycolabadmin

This review examines how a fungal biomarker called beta-D-glucan (BDG) can help doctors diagnose yeast infections in the abdomens of critically ill patients. While BDG tests in the blood are available, they give many false positives. Testing BDG directly in fluid from the abdomen appears more accurate, especially when combined with blood tests. However, more research is needed before hospitals widely adopt this approach in daily practice.

Shared Vision for Improving Outcomes for Serious Fungal Diseases: Report of a Patient, Caregiver, and Clinician Summit

mycolabadmin

Patients with serious fungal infections face significant challenges including long delays before diagnosis, substantial emotional and financial burden, and lasting effects on quality of life. A summit brought together patients, their caregivers, and fungal disease experts to share experiences and identify priorities for improving care. The group identified needs for better diagnostic tools, new treatments, improved medical education about fungal diseases, and patient support programs to help future patients and their families navigate fungal infections more effectively.

Impact of Phellinus gilvus mycelia on growth, immunity and fecal microbiota in weaned piglets

mycolabadmin

Researchers tested whether a medicinal mushroom called Phellinus gilvus could replace antibiotics in pig feed as a growth promoter. Over 28 days, piglets fed mushroom-supplemented diets grew as well as those given antibiotics while showing even better immune system activation. Unlike antibiotics that drastically changed the gut bacteria composition, the mushroom only slightly modified it while still reducing harmful E. coli bacteria. This suggests the mushroom could be a safer alternative to antibiotics in pig farming.

PRMT5 promotes cellulase production by regulating the expression of cellulase gene eg2 through histone methylation in Ganoderma lucidum

mycolabadmin

Scientists discovered that a protein called PRMT5 in Ganoderma lucidum mushroom plays a key role in producing cellulase enzymes that break down plant cellulose. By controlling a specific gene (eg2) through a process called histone methylation, PRMT5 increases cellulase production. This finding could help develop more efficient ways to convert agricultural waste like corn straw into useful sugars for biofuels and other industrial products.

First case of fungemia caused by a rare and pan-echinocandin resistant yeast Sporopachydermia lactativora in China

mycolabadmin

A 37-year-old woman with leukemia developed a rare blood infection caused by a yeast called Sporopachydermia lactativora, which had never been documented to cause bloodstream infection in China before. This yeast is naturally resistant to a common class of antifungal drugs called echinocandins, making it particularly challenging to treat. However, the patient responded well to a different antifungal medication called voriconazole and fully recovered. The researchers suggest that this unusual yeast should be monitored in hospitals as it could become a more common infection in vulnerable patients.

Local mushroom poisoning: a case report study

mycolabadmin

A 26-year-old woman became severely ill after eating poisonous mountain mushrooms she mistakenly thought were edible. She developed serious heart problems, elevated liver enzymes, and inflammation of the pancreas, requiring intensive care and a heart defibrillator shock. After receiving NAC (N-acetylcysteine) infusions and dialysis for a week, she gradually recovered and was eventually discharged in good condition. This case highlights the dangers of wild mushroom foraging and the importance of seeking immediate medical attention if poisoning is suspected.

Prevalence of Candida and Other Yeasts in Vulvovaginal Infections during Pregnancy: A 10-Year Serbian Survey

mycolabadmin

This study examined yeast infections in pregnant Serbian women over 10 years, finding that nearly half had vulvovaginal yeast infections. While Candida albicans remained the most common cause, other yeast species are increasingly found and can be harder to treat. The research emphasizes the importance of accurate laboratory identification of yeast species to guide proper antifungal treatment and prevent serious complications for both mother and newborn.

Treatment and diagnostic challenges associated with the novel and rapidly emerging antifungal-resistant dermatophyte, Trichophyton indotineae

mycolabadmin

A new type of fungal infection called Trichophyton indotineae has emerged and spread globally, particularly from India. It causes widespread skin infections that are difficult to treat because the fungus resists common antifungal medications. Doctors and laboratories need to be aware of this infection to properly identify it and choose effective treatments, especially for patients with travel history to affected regions.

In silico screening and molecular dynamics analysis of natural DHPS enzyme inhibitors targeting Acinetobacter baumannii

mycolabadmin

Researchers used computer modeling to find natural compounds from plants and mushrooms that can inhibit a key bacterial enzyme (DHPS) in dangerous antibiotic-resistant bacteria called Acinetobacter baumannii. They tested thousands of natural molecules and identified two promising candidates that bind strongly to this enzyme and prevent bacteria from producing folic acid, which they need to survive. The study suggests these natural compounds could potentially be developed into new antibiotics to fight infections caused by drug-resistant bacteria.

Research Topic: Medicinal